Ellen Leinfuss is senior vice president and chief commercial officer for Certara’s Simcyp Division. Simcyp is the global leader in mechanistic modeling, employing its Simcyp Simulator physiologically based pharmacokinetic (PBPK) and quantitative systems pharmacology (QSP) immunogenicity, immuno-oncology, vaccine, and gene therapy modeling and simulation platforms. Ellen has worked for Certara for eight years, serving for several years as chief marketing officer for the corporation. She has a BA in chemistry and an MBA in marketing.
Advancing Oral Drug Development Using MIFD
October 16th 2023Model informed formulation development uses in-silico modeling and simulation to identify and/or refine promising formulations faster and cheaper, support formulation strategy and increasingly, demonstrate virtual bioequivalence and obtain biowaivers.